NDC 0037-0113

Butisol Sodium

Butabarbital Sodium

Butisol Sodium is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Meda Pharmaceuticals. The primary component is Butabarbital Sodium.

• Product ID: 0037-0113_0e16e8e0-efa1-43df-aba4-2e3cad8af753
• NDC: 0037-0113
• Product Type: Human Prescription Drug
• Proprietary Name: Butisol Sodium
• Generic Name: Butabarbital Sodium
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 1939-08-01
• Marketing End Date: 2020-01-31
• Marketing Category: NDA / NDA
• Application Number: NDA000793
• Labeler Name: Meda Pharmaceuticals
• Substance Name: BUTABARBITAL SODIUM
• Active Ingredient Strength: 30 mg/1
• DEA Schedule: CIII
• NDC Exclude Flag: N

Packaging

NDC 0037-0113-60

100 TABLET in 1 BOTTLE (0037-0113-60)

• Marketing Start Date: 1939-08-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0037-0113-60 [00037011360]

Butisol Sodium TABLET

• Marketing Category: NDA
• Application Number: NDA000793
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 1939-08-01
• Marketing End Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
BUTABARBITAL SODIUM	30 mg/1

OpenFDA Data

• SPL SET ID: 7883bbc0-0874-11dc-a818-0002a5d5c51b
• Manufacturer:
  • Meda Pharmaceuticals
• UNII:
  • 9WTD50I918
• RxNorm Concept Unique ID - RxCUI:
  • 1251616
  • 1251614
• UPC Code:
  • 0300370113608